731 related articles for article (PubMed ID: 17610859)
21. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
22. Role of a novel tetrodotoxin-resistant sodium channel in the nitrergic relaxation of corpus cavernosum from the South American rattlesnake Crotalus durissus terrificus.
Capel RO; Mónica FZ; Porto M; Barillas S; Muscará MN; Teixeira SA; Arruda AM; Pissinatti L; Pissinatti A; Schenka AA; Antunes E; Nahoum C; Cogo JC; de Oliveira MA; De Nucci G
J Sex Med; 2011 Jun; 8(6):1616-25. PubMed ID: 21477017
[TBL] [Abstract][Full Text] [Related]
23. The nitric oxide-cGMP signaling pathway plays a significant role in tolerance to the analgesic effect of morphine.
Ozdemir E; Bagcivan I; Durmus N; Altun A; Gursoy S
Can J Physiol Pharmacol; 2011 Feb; 89(2):89-95. PubMed ID: 21326339
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
Priviero FB; Zemse SM; Teixeira CE; Webb RC
Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide generated by the compound RuBPY promotes the vascular smooth cell membrane hyperpolarization.
Pereira AC; Lunardi CN; Paulo M; da Silva RS; Bendhack LM
Eur J Pharm Sci; 2013 Mar; 48(4-5):604-10. PubMed ID: 23333503
[TBL] [Abstract][Full Text] [Related]
28. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
[TBL] [Abstract][Full Text] [Related]
29. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.
Buus NH; Simonsen U; Pilegaard HK; Mulvany MJ
Br J Pharmacol; 2000 Jan; 129(1):184-92. PubMed ID: 10694219
[TBL] [Abstract][Full Text] [Related]
31. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
33. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
34. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries.
Sand AE; Andersson E; Fried G
Acta Physiol Scand; 2002 Mar; 174(3):217-23. PubMed ID: 11906320
[TBL] [Abstract][Full Text] [Related]
35. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
[TBL] [Abstract][Full Text] [Related]
37. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
38. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
Jones AW; Durante W; Korthuis RJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
[TBL] [Abstract][Full Text] [Related]
39. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms.
Teixeira CE; Priviero FB; Todd J; Webb RC
Hypertension; 2006 Mar; 47(3):596-602. PubMed ID: 16391173
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
Pearce WJ; Williams JM; White CR; Lincoln TM
J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]